Dyoksometyltetrahydropyrymydyn | Methyluracil Renewal tablets 500 mg 50 pcs.
Special Price
$13.80
Regular Price
$24.00
In stock
SKU
BID472308
Latin name
Methyluracil
Methyluracil
Latin name
Methyluracil
release form weave
packaging 50 pcs
Pharmacological action
Local anesthetic that blocks nerve endings. When applied topically, it penetrates well into tissues. Compared with tetracaine and other local anesthetics, it has a less pronounced irritant effect on the conjunctiva and cornea.
Superficial anesthesia of the conjunctiva and cornea after applying eye drops occurs after 30 seconds and lasts for 15 minutes.
Pharmacokinetics
Inocaine easily penetrates the stroma of the cornea after a single instillation of it into the conjunctival cavity. Over the next 15 minutes, a quantitative decrease in the stromal concentration of the drug is observed, stimulates cellular and humoral factors of immunity.
It has an anti-inflammatory effect, which is associated with the ability to inhibit the activity of proteolytic enzymes. Effective in diseases of the gastrointestinal tract, which is associated with the normalization of nucleic acid metabolism in the mucous membrane.
Indications
Leukopenia (mild, including arising from chemotherapy for malignant neoplasms, with x-ray and radiation therapy).
Agranulocytic tonsillitis.
Alimentary toxic aukia.
anemia.
Thrombocytopenia.
Benzene intoxication.
Radiation sickness.
Reconvalescence (after severe infections).
Peptic ulcer of the stomach and duodenum.
Flaccid wounds.
Burns.
bone fractures.
Pancreatitis.
Contraindications
Children under 3 years.
hypersensitivity.
Leukemia (leukemic forms).
Lymphogranulomatosis.
Hemoblastosis.
Malignant bone marrow disease.
Use during pregnancy and lactation
During pregnancy and lactation, the estimated benefits to the mother and the potential risk to the fetus and the baby should be correlated.
Composition
1 tablet contains:
Active ingredient:
methyluracil 0.5 g
Excipients:
mg starch 130 mg potato ,
povidone K30 49 mg,
talcum powder 14 mg.
Dosage and administration
Inside, during or after a meal - 0, 5 g 4 times a day (if necessary up to 6 times a day)
for children 3–8 years old - 0.25 g each,
over 8 years old - 0.25 g 3 times a day.
The course for diseases of the gastrointestinal tract - 30-40 days in other cases may be shorter.
Side effects
Headache
dizziness
allergic reactions.
Drug Interactions
Enhances the radioprotective effect of cystamine.
Storage conditions
Store in a dry, dark place at a temperature not exceeding 25 РC.
Expiration
5 years.
prescription drugstore
prescription
lekarstvennaja form
tablets
Methyluracil
release form weave
packaging 50 pcs
Pharmacological action
Local anesthetic that blocks nerve endings. When applied topically, it penetrates well into tissues. Compared with tetracaine and other local anesthetics, it has a less pronounced irritant effect on the conjunctiva and cornea.
Superficial anesthesia of the conjunctiva and cornea after applying eye drops occurs after 30 seconds and lasts for 15 minutes.
Pharmacokinetics
Inocaine easily penetrates the stroma of the cornea after a single instillation of it into the conjunctival cavity. Over the next 15 minutes, a quantitative decrease in the stromal concentration of the drug is observed, stimulates cellular and humoral factors of immunity.
It has an anti-inflammatory effect, which is associated with the ability to inhibit the activity of proteolytic enzymes. Effective in diseases of the gastrointestinal tract, which is associated with the normalization of nucleic acid metabolism in the mucous membrane.
Indications
Leukopenia (mild, including arising from chemotherapy for malignant neoplasms, with x-ray and radiation therapy).
Agranulocytic tonsillitis.
Alimentary toxic aukia.
anemia.
Thrombocytopenia.
Benzene intoxication.
Radiation sickness.
Reconvalescence (after severe infections).
Peptic ulcer of the stomach and duodenum.
Flaccid wounds.
Burns.
bone fractures.
Pancreatitis.
Contraindications
Children under 3 years.
hypersensitivity.
Leukemia (leukemic forms).
Lymphogranulomatosis.
Hemoblastosis.
Malignant bone marrow disease.
Use during pregnancy and lactation
During pregnancy and lactation, the estimated benefits to the mother and the potential risk to the fetus and the baby should be correlated.
Composition
1 tablet contains:
Active ingredient:
methyluracil 0.5 g
Excipients:
mg starch 130 mg potato ,
povidone K30 49 mg,
talcum powder 14 mg.
Dosage and administration
Inside, during or after a meal - 0, 5 g 4 times a day (if necessary up to 6 times a day)
for children 3–8 years old - 0.25 g each,
over 8 years old - 0.25 g 3 times a day.
The course for diseases of the gastrointestinal tract - 30-40 days in other cases may be shorter.
Side effects
Headache
dizziness
allergic reactions.
Drug Interactions
Enhances the radioprotective effect of cystamine.
Storage conditions
Store in a dry, dark place at a temperature not exceeding 25 РC.
Expiration
5 years.
prescription drugstore
prescription
lekarstvennaja form
tablets
Submit your review to Earn 10 Reward Points click here to login
Write Your Own Review